Moody Aldrich Partners’s Medpace MEDP Stock Holding History

Moody Aldrich Partners’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,110	Closed	-$449K	–	223
2024 Q1	$449K	Buy	+1,110	New	+$390K	0.08%	149

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Moody Aldrich Partners's MEDP Position: Q2 2024 in Review

Moody Aldrich Partners sold out of Medpace (MEDP) in Q2 2024, closing a stake of 1,110 shares — an estimated $449K sold.

Moody Aldrich Partners first reported a position in MEDP in Q1 2024 and held it in 1 quarter. The position peaked at $449K in Q1 2024. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

Moody Aldrich Partners reported no remaining Medpace position as of Q2 2024 after selling out during the quarter.
Moody Aldrich Partners sold 1,110 Medpace shares in Q2 2024, an estimated $449K.
Moody Aldrich Partners first reported a position in Medpace in Q1 2024 and held it in 1 quarter.
Moody Aldrich Partners's Medpace position peaked at $449K in Q1 2024.
623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on Moody Aldrich Partners's 13F filing for Q2 2024, filed 24 Jul 2024.